Business
Regeneron backs $75M series A for antibody upstart Infinimmune - Fierce Biotech

What the report says
Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm. | Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A hea…
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Parliamentary Pension Scheme Halts Kampala Building Investment Over Lack of DetailsNile Post
Ecobank Uganda Launches Digital Merchant Cash Advance of Up to Shs70 MillionNile Post
Museveni to flag off construction of Kampala Storage TerminalNile Post
Uganda Targets French Tourism Market at IFTM Top Resa 2026Nile Post